Search

everythinglearnresearchcommunity

for

Search:↓

Transverse scalp biopsy sections help diagnose different alopecias by showing hair follicle details and inflammation patterns.

Antioxidant nanoparticles show promise for treating inflammatory diseases but need more research for safe and effective use.

ATR-FTIR spectroscopy could help monitor alopecia areata treatment response non-invasively.

Janus kinase inhibitors can regrow hair in alopecia areata but may cause side effects and hair loss may return if treatment stops.

Early onset, severe types, nail changes, family history, and body hair loss worsen alopecia areata prognosis; sticking to treatment helps.

Mesenchymal stem cells show promise for treating various skin conditions and may help regenerate hair.

Folate receptor β helps suppress the immune system in macrophages and affects cancer growth and hair health.

Nivolumab treatment led to hair regrowth in a man with metastatic melanoma and alopecia areata.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

Early baldness in men may indicate risks for obesity, metabolic syndrome, insulin resistance, and heart disease, similar to women with PCOS. Alopecia areata is often linked with autoimmune diseases and mental health issues. Certain hair disorders are due to genetic issues, and chemotherapy can cause hair loss through specific biological pathways. Iron deficiency's link to hair loss is still disputed.

Steroid treatment improved both gut and nerve symptoms in a man with Cronkhite–Canada syndrome.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

IFN-γ production by CD4 T cells is crucial for causing alopecia areata.

International guidelines for treating alopecia areata vary, focusing on different treatment options and related health issues.

Cosmeceuticals like sunscreens may trigger frontal fibrosing alopecia, but more research is needed.

Hair specialists vary in testing for alopecia areata, highlighting the need for standard guidelines.

Oral betamethasone mini-pulses effectively treat moderate to severe alopecia areata with manageable side effects.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

Pertussis toxin may contribute to hair loss in alopecia areata.

Consider systemic lupus erythematosus in patients with unexplained intracranial hypertension.

Stem-cell therapy shows promise for skin conditions but needs more research.

Alopecia Areata affects people of all ages worldwide, is likely caused by genetic and environmental factors, and can lead to stress and depression, highlighting the need for treatments that address both physical and mental health.

The document concludes that understanding hair follicle histology and the hair cycle is crucial for diagnosing alopecia.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

The study concluded that Frontal fibrosing alopecia can affect younger people, is often missed in men, and may be autoimmune-related.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

Some lesser-known causes of PCOS include autoimmune issues, genetic mutations, and changes in the body's microbiome.